Understanding how O-GlcNAcase is regulated in the body
Structural insights into the functional regulation of O-GlcNAcase
['FUNDING_R01'] · UNIVERSITY OF WISCONSIN-MADISON · NIH-11060406
This study is exploring a special enzyme that helps with important processes in our bodies, especially related to cancer, and it's designed to support a promising student from an underrepresented background in learning how to discover new treatments.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF WISCONSIN-MADISON (nih funded) |
| Locations | 1 site (MADISON, UNITED STATES) |
| Trial ID | NIH-11060406 on ClinicalTrials.gov |
What this research studies
This research focuses on the enzyme O-GlcNAcase, which plays a crucial role in protein glycosylation, a process that affects many biological functions and diseases, including cancer. The project aims to provide personalized mentoring and training for an underrepresented minority predoctoral student, enhancing their skills in drug discovery and biomedical research. By investigating the structural aspects of O-GlcNAcase, the research seeks to uncover insights that could lead to the development of effective therapies for malignancies. The approach combines hands-on training with advanced research methodologies to foster the next generation of scientists.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals interested in the molecular mechanisms of cancer and those who may benefit from novel drug therapies targeting glycosylation processes.
Not a fit: Patients who are not affected by malignancies or do not have an interest in the underlying biochemical processes may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating various cancers by targeting the regulation of O-GlcNAcase.
How similar studies have performed: Previous research has shown promising results in targeting glycosylation processes in cancer treatment, indicating that this approach has potential for success.
Where this research is happening
MADISON, UNITED STATES
- UNIVERSITY OF WISCONSIN-MADISON — MADISON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: JIANG, JIAOYANG — UNIVERSITY OF WISCONSIN-MADISON
- Study coordinator: JIANG, JIAOYANG
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers, Disease, Disorder